Search research articles
Contact Us
Filters
Showing results (31-40 of 149) with videos related to
Page
of 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1992
Kinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease
M Contin, R Riva, P Martinelli, et al.
Therapeutic Drug Monitoring
|
December 22, 1999
Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy
M Contin, R Riva, F Albani, et al.
Epilepsia
|
September 1, 1977
Phenytoin encephalopathy as probable idiosyncratic reaction: case report
G Ambrosetto, C A Tassinari, A Baruzzi, et al.
Journal of Chromatography
|
March 13, 1981
Rapid quantitation of flurazepam and its major metabolite, N-desalkylflurazepam, in human plasma by gas-liquid chromatography with electron-capture detection
R Riva, M de Anna, F Albani, et al.
Clinical Neuropharmacology
|
October 23, 1997
Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up study
M Contin, R Riva, P Martinelli, et al.
British Medical Journal (Clinical Research Ed.)
|
August 22, 1981
Benign familial tremor treated with primidone
G Procaccianti, P Martinelli, A Baruzzi, et al.
Annals of Neurology
|
November 15, 2001
Pharmacodynamic modeling of oral levodopa in Parkinson's disease
M Contin, R Riva, F Albani, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration
A Baruzzi, M Contin, E Perucca, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
May 1, 1985
Propranolol plasma binding and serum lipids during chronic therapy in migraine patients
F Albani, R Riva, P Cortelli, et al.
Clinical Neuropharmacology
|
February 1, 1989
Increased dosage of carbidopa in parkinsonian patients on low carbidopa-levodopa regimen. Effect on levodopa bioavailability
M Contin, R Riva, P Martinelli, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 149) with videos related to
Sort By:
Page
of 15
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1992
Kinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease
M Contin, R Riva, P Martinelli, et al.
Therapeutic Drug Monitoring
|
December 22, 1999
Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy
M Contin, R Riva, F Albani, et al.
Epilepsia
|
September 1, 1977
Phenytoin encephalopathy as probable idiosyncratic reaction: case report
G Ambrosetto, C A Tassinari, A Baruzzi, et al.
Journal of Chromatography
|
March 13, 1981
Rapid quantitation of flurazepam and its major metabolite, N-desalkylflurazepam, in human plasma by gas-liquid chromatography with electron-capture detection
R Riva, M de Anna, F Albani, et al.
Clinical Neuropharmacology
|
October 23, 1997
Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up study
M Contin, R Riva, P Martinelli, et al.
British Medical Journal (Clinical Research Ed.)
|
August 22, 1981
Benign familial tremor treated with primidone
G Procaccianti, P Martinelli, A Baruzzi, et al.
Annals of Neurology
|
November 15, 2001
Pharmacodynamic modeling of oral levodopa in Parkinson's disease
M Contin, R Riva, F Albani, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration
A Baruzzi, M Contin, E Perucca, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
May 1, 1985
Propranolol plasma binding and serum lipids during chronic therapy in migraine patients
F Albani, R Riva, P Cortelli, et al.
Clinical Neuropharmacology
|
February 1, 1989
Increased dosage of carbidopa in parkinsonian patients on low carbidopa-levodopa regimen. Effect on levodopa bioavailability
M Contin, R Riva, P Martinelli, et al.
Page
of 15